Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel. more
Time Frame | ICCM | Sector | S&P500 |
---|---|---|---|
1-Week Return | 26.83% | -3.72% | -0.05% |
1-Month Return | 73.33% | -1.85% | 2.75% |
3-Month Return | 69.11% | -11.4% | 7.4% |
6-Month Return | 35.08% | -4.41% | 10.47% |
1-Year Return | 10.92% | 4.13% | 27.57% |
3-Year Return | -67.3% | 0.3% | 29.56% |
5-Year Return | -43.48% | 36.62% | 89.3% |
10-Year Return | -27.41% | 106.81% | 206.09% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 1.66M | 4.08M | 4.14M | 3.08M | 3.23M | [{"date":"2019-12-31","value":40.06,"profit":true},{"date":"2020-12-31","value":98.71,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":74.55,"profit":true},{"date":"2023-12-31","value":78.03,"profit":true}] |
Cost of Revenue | 1.08M | 1.43M | 1.94M | 1.64M | 1.93M | [{"date":"2019-12-31","value":55.65,"profit":true},{"date":"2020-12-31","value":73.4,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":84.41,"profit":true},{"date":"2023-12-31","value":99.28,"profit":true}] |
Gross Profit | 576.41K | 2.66M | 2.19M | 1.45M | 1.30M | [{"date":"2019-12-31","value":21.68,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":82.57,"profit":true},{"date":"2022-12-31","value":54.36,"profit":true},{"date":"2023-12-31","value":48.9,"profit":true}] |
Gross Margin | 34.77% | 65.08% | 53.04% | 46.84% | 40.26% | [{"date":"2019-12-31","value":53.43,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":81.5,"profit":true},{"date":"2022-12-31","value":71.97,"profit":true},{"date":"2023-12-31","value":61.86,"profit":true}] |
Operating Expenses | 5.19M | 7.02M | 11.92M | 18.18M | 16.88M | [{"date":"2019-12-31","value":28.51,"profit":true},{"date":"2020-12-31","value":38.61,"profit":true},{"date":"2021-12-31","value":65.55,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.81,"profit":true}] |
Operating Income | (4.61M) | (4.36M) | (9.72M) | (16.74M) | (15.58M) | [{"date":"2019-12-31","value":-460869816,"profit":false},{"date":"2020-12-31","value":-436161776,"profit":false},{"date":"2021-12-31","value":-972400000,"profit":false},{"date":"2022-12-31","value":-1673900000,"profit":false},{"date":"2023-12-31","value":-1557600000,"profit":false}] |
Total Non-Operating Income/Expense | (863.18K) | (468.00K) | (342.00K) | (478.00K) | 1.85M | [{"date":"2019-12-31","value":-46.71,"profit":false},{"date":"2020-12-31","value":-25.32,"profit":false},{"date":"2021-12-31","value":-18.51,"profit":false},{"date":"2022-12-31","value":-25.87,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (4.77M) | (4.69M) | (9.89M) | (16.98M) | (14.65M) | [{"date":"2019-12-31","value":-477388241,"profit":false},{"date":"2020-12-31","value":-469033291,"profit":false},{"date":"2021-12-31","value":-989500000,"profit":false},{"date":"2022-12-31","value":-1697800000,"profit":false},{"date":"2023-12-31","value":-1465200000,"profit":false}] |
Income Taxes | (13.57K) | 86.77K | 171.00K | 239.00K | 155.10K | [{"date":"2019-12-31","value":-5.68,"profit":false},{"date":"2020-12-31","value":36.3,"profit":true},{"date":"2021-12-31","value":71.55,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":64.9,"profit":true}] |
Income After Taxes | (4.76M) | (4.78M) | (10.07M) | (17.22M) | (14.81M) | [{"date":"2019-12-31","value":-476030958,"profit":false},{"date":"2020-12-31","value":-477709791,"profit":false},{"date":"2021-12-31","value":-1006600000,"profit":false},{"date":"2022-12-31","value":-1721700000,"profit":false},{"date":"2023-12-31","value":-1480710500,"profit":false}] |
Income From Continuous Operations | (16.53M) | (15.08M) | (9.89M) | (16.98M) | (14.65M) | [{"date":"2019-12-31","value":-1653100000,"profit":false},{"date":"2020-12-31","value":-1508200000,"profit":false},{"date":"2021-12-31","value":-989500000,"profit":false},{"date":"2022-12-31","value":-1697800000,"profit":false},{"date":"2023-12-31","value":-1465200000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (4.76M) | (4.78M) | (10.07M) | (17.22M) | (14.65M) | [{"date":"2019-12-31","value":-476030958,"profit":false},{"date":"2020-12-31","value":-477709879,"profit":false},{"date":"2021-12-31","value":-1006600000,"profit":false},{"date":"2022-12-31","value":-1721700000,"profit":false},{"date":"2023-12-31","value":-1465200000,"profit":false}] |
EPS (Diluted) | (0.30) | (0.29) | - | (0.39) | (0.31) | [{"date":"2019-12-31","value":-30.49,"profit":false},{"date":"2020-12-31","value":-29.41,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-38.84,"profit":false},{"date":"2023-12-31","value":-31,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
ICCM | |
---|---|
Cash Ratio | 2.14 |
Current Ratio | 2.67 |
Quick Ratio | 2.27 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
ICCM | |
---|---|
ROA (LTM) | -47.36% |
ROE (LTM) | -94.22% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
ICCM | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.34 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.66 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
ICCM | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 17.80 |
P/B | 5.90 |
Price/FCF | NM |
EV/R | 13.40 |
EV/Ebitda | NM |
Icecure Medical (ICCM) share price today is $1.04
Yes, Indians can buy shares of Icecure Medical (ICCM) on Vested. To buy Icecure Medical from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ICCM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Icecure Medical (ICCM) via the Vested app. You can start investing in Icecure Medical (ICCM) with a minimum investment of $1.
You can invest in shares of Icecure Medical (ICCM) via Vested in three simple steps:
The 52-week high price of Icecure Medical (ICCM) is $1.57. The 52-week low price of Icecure Medical (ICCM) is $0.48.
The price-to-earnings (P/E) ratio of Icecure Medical (ICCM) is
The price-to-book (P/B) ratio of Icecure Medical (ICCM) is 5.90
The dividend yield of Icecure Medical (ICCM) is 0.00%
The market capitalization of Icecure Medical (ICCM) is $59.39M
The stock symbol (or ticker) of Icecure Medical is ICCM